Adage Capital Partners’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,027,291
| Closed | -$2.33M | – | 1026 |
|
|
2022
Q4 | $2.33M | Sell |
1,027,291
-1,000,000
| -49% | -$2.27M | 0.01% | 804 |
|
|
2022
Q3 | $2.19M | Hold |
2,027,291
| – | – | 0.01% | 849 |
|
|
2022
Q2 | $5.37M | Hold |
2,027,291
| – | – | 0.01% | 790 |
|
|
2022
Q1 | $8.35M | Buy |
2,027,291
+103,591
| +5% | +$427K | 0.02% | 743 |
|
|
2021
Q4 | $17.4M | Buy |
1,923,700
+96,408
| +5% | +$871K | 0.03% | 523 |
|
|
2021
Q3 | $24.7M | Hold |
1,827,292
| – | – | 0.05% | 380 |
|
|
2021
Q2 | $35.8M | Buy |
+1,827,292
| New | +$35.8M | 0.07% | 292 |
|